Company Profiles

driven by the PitchBook Platform

Immunome

Description

Developer of novel immunotherapies and cancer therapeutics products. The company is developing a pipeline of cancer immunotherapies produced by an immunotherapy discovery engine. Its proprietary RealMAb technology enables the simultaneous discovery of novel antigens and the cognate native human antibodies that target those antigens.

2006

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$5M

Latest Deal Amount

$16.6M

Total Amount Raised

Description

Developer of novel immunotherapies and cancer therapeutics products. The company is developing a pipeline of cancer immunotherapies produced by an immunotherapy discovery engine. Its proprietary RealMAb technology enables the simultaneous discovery of novel antigens and the cognate native human antibodies that target those antigens.

Website:

www.immunome.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology

Primary Office

3001 Market Street Philadelphia, PA 19104United States +1 (215) 239-6274
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Immunome's full profile, request a free trial.

Immunome Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Immunome Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioAdvanceVenture CapitalMinority000 0000000 0000
Delaware Crossing Investor GroupVenture CapitalMinority000 0000000 0000
DeSimone Group InvestmentsFamily OfficeMinority000 0000000 0000
Harvard Business School Alumni Angels of Greater NYAngel GroupMinority000 0000000 0000
Mid-Atlantic Angel GroupAngel GroupMinority000 0000000 0000
BioAdvance Venture Capital
Delaware Crossing Investor Group Venture Capital
DeSimone Group Investments Family Office
Harvard Business School Alumni Angels of Greater NY Angel Group
Mid-Atlantic Angel Group Angel Group

Immunome Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Jane Hollingsworth JDChief Executive Officer & Executive Chairman
Michael Morin Ph.DPresident & Chief Scientific Officer
Joel SussmanChief Financial Officer
David Kutcher JDInterim Chief Financial Officer
Joan Lau Ph.DChief Operating Officer
Jane Hollingsworth JD Chief Executive Officer & Executive Chairman
Michael Morin Ph.D President & Chief Scientific Officer
Joel Sussman Chief Financial Officer
David Kutcher JD Interim Chief Financial Officer
Joan Lau Ph.D Chief Operating Officer

Immunome Board Members (7)

NameRepresentingRoleSinceContact
Info
Barbara Schilberg JDBioAdvanceManaging Director & Chief Executive Officer000 0000
Gregory Harriman MDBioAdvanceVenture Partner000 0000
I. Morris IIISelfBoard Member000 0000
Jane Hollingsworth JDImmunomeChief Executive Officer & Executive Chairman000 0000
Michael RappSelfBoard Member000 0000
Barbara Schilberg JD Managing Director & Chief Executive Officer BioAdvance
Gregory Harriman MD Venture Partner BioAdvance
I. Morris III Board Member Self
Jane Hollingsworth JD Chief Executive Officer & Executive Chairman Immunome
Michael Rapp Board Member Self
Request full access to PitchBook